{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T15:08:49Z","timestamp":1726412929352},"reference-count":30,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,3,17]],"date-time":"2005-03-17T00:00:00Z","timestamp":1111017600000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold>  <jats:italic>Helicobacter pylori<\/jats:italic> treatment failure is a growing problem in daily practice.<\/jats:p><jats:p><jats:bold>Aim:\u2002<\/jats:bold> To determine the efficacy of the combination of rabeprazole, levofloxacin and furazolidone as a rescue therapy.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Duodenal ulcer patients previously submitted, without success, to at least two <jats:italic>H. pylori<\/jats:italic> treatment regimens were included. Gastroscopy (urease test, histological examination and culture) and <jats:sup>13<\/jats:sup>C\u2010urea breath test were performed. All patients received a combination of rabeprazole 20\u2003mg, levofloxacin 500\u2003mg and furazolidone 200\u2003mg (two tablets) administered in a single dose in the morning for 10\u2003days. Clinical examination and a new <jats:sup>13<\/jats:sup>C\u2010urea breath test were performed 90\u2003days after therapy.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Twelve patients (eight females and four males), mean age 43 (30\u201358) years were included. Two patients failed to complete the treatment because of nausea and vomiting. Ten patients completed the study and took all the medications as advised. Culture was obtained in six patients: 100 and 83% of the samples were sensitive to furazolidone and levofloxacin, respectively. Per\u2010protocol and intention\u2010to\u2010treat eradication rates were 100 and 83% (<jats:italic>P<\/jats:italic>\u2003=\u20030.019).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> the combination of rabeprazole, levofloxacin and furazolidone in a single daily dose for 10\u2003days constitutes a highly\u2010effective and low\u2010cost alternative as a third\u2010line therapy in patients infected with <jats:italic>H. pylori<\/jats:italic>.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2005.02370.x","type":"journal-article","created":{"date-parts":[[2005,3,17]],"date-time":"2005-03-17T11:03:21Z","timestamp":1111057401000},"page":"783-787","source":"Crossref","is-referenced-by-count":48,"title":["New once\u2010daily, highly effective rescue triple therapy after multiple <i>Helicobacter pylori<\/i> treatment failures: a pilot study"],"prefix":"10.1111","volume":"21","author":[{"given":"L. G. V.","family":"Coelho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. D.","family":"Moretzsohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. L. S.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C. F.","family":"Passos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Cindr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Cerqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pedrazzoli\u2010J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. P.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,3,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199409000-00004"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.8"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03174.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.0160s1024.x"},{"key":"e_1_2_6_7_2","first-page":"1481","article-title":"Helicobacter pylori and peptic ulcer disease: current evidence for management strategies","volume":"44","author":"Chiba N","year":"1998","journal-title":"Can Fam Physician"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.022111"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.2002.00056.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01169.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.2003.00128.x"},{"key":"e_1_2_6_12_2","first-page":"463","article-title":"Rabeprazol\/levofloxacin based triple therapy as a salvatage treatment after failure of H. pylori eradication with standard regimens","volume":"8","author":"Orsi P","year":"2003","journal-title":"Helicobacter"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(03)00059-8"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(08)80589-6"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.2002.00087.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X1999001200007"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.2000.00011.x"},{"key":"e_1_2_6_18_2","volume-title":"An Introduction to Categorical Data Analysis","author":"Agrest A.","year":"1995"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07427.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(03)00288-X"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01276.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00846.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)81821-8"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01676.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199447060-00008"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.2003.00128.x"},{"key":"e_1_2_6_27_2","first-page":"571","article-title":"In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates","volume":"52","author":"Matsuzaki K","year":"1999","journal-title":"Jpn J Antibiot"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909091336"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)80728-3"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01393.x"},{"issue":"2","key":"e_1_2_6_31_2","first-page":"A88","article-title":"Previous therapy with omeprazol: does it reduce H. pylori eradication efficacy with the new triple therapies?","volume":"43","author":"Gisbert JP","year":"1998","journal-title":"Gut"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2005.02370.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2005.02370.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:55:32Z","timestamp":1697230532000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2005.02370.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1365-2036.2005.02370.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02370.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}